What is the share price of Paras Healthcare Ltd (PARASHLTH)?

Company share prices are keep on changing according to the market conditions. The current trading price of Paras Healthcare Ltd (PARASHLTH) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Paras Healthcare?

The latest standalone P/E ratio of Paras Healthcare as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Paras Healthcare Ltd (PARASHLTH)?

The latest standalone P/B ratio of Paras Healthcare Ltd (PARASHLTH) as of 01-Jan-1970 is 0.00.

What is the 52-week high and low of Paras Healthcare Ltd (PARASHLTH)?

The 52-week high of Paras Healthcare Ltd (PARASHLTH) is Rs. 0.00 and the 52-week low is Rs. 0.00.

Sr. No.	Received from	Pending at the end of last month	Received	Resolved*	Total Pending #	Pending complaints >3months	Average Resolution time^ (in days)
1	Directly from Investors	0	0	0	0	0	0
2	SEBI (SCORES)	0	0	0	0	0	0
3	Other Sources (if any)	0	0	0	0	0	0
	Grand Total	0	0	0	0	0	0

Sr. No.	Month	Carried forward from previous month	Received	Resolved*	Pending#
1	Jun, 2026	0	0	0	0
2	Jul, 2026	0	0	0	0
3	Aug, 2026	0	0	0	0
	Grand Total	0	0	0	0

Sr. No.	Fin. Year	Received	Resolved*
1	2022-23	1	1
2	2023-24	0	0
3	2024-25	0	0
4	2025-26	1	1
	Grand Total	2	2

Paras Healthcare Ltd (PARASHLTH)

Name: Paras Healthcare Ltd (PARASHLTH)
Brand: Paras Healthcare

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: PARASHLTH Hospital & Healthcare Services | Small Cap | Paras Healthcare Share Price

BSE Share Price
Not Listed

Paras Healthcare Ltd (PARASHLTH)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: PARASHLTH Hospital & Healthcare Services | Small Cap | Paras Healthcare Share Price

BSE Share Price
Not Listed

Key Metrics

Valuation Multiples

Market Cap

₹0 Cr.

Current Price

₹0

52-Week Low / High

₹0 / 0

TTM EPS

TTM Sales

Book Value per Share

P/E Ratio

Industry PE

86.8

Price to Book (P/B)

Price to Sales (P/S)

EV/EBITDA

Dividend Yield

NAN%

Profitability Efficiency

Return on Equity (ROE)

12.99%

Return on Capital Employed (ROCE)

17.30%

Return on Assets (ROA)

2.26%

Operating Profit Margin

19.8%

Net Profit Margin

2.73%

Gross Profit Margin

13.7%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

20.36%

Operating Profit Growth (1 Year)

Improving versus 3-year growth rate

126.87%

Net Profit Growth (1 Year)

Asset Quality

Promoter Holding

Pledged shares (%) of Promoter's holding (%)

Reserves

Equity

₹0 Cr.

Face Value

All Time Low / High

- / -

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26	TTM
ROCE % ⓘ	8.6%	19.4%	12.5%	10.3%	6.9%	15.2%	14.9%	20%	8.9%	17.4%	-
Growth Parameters ⓘ
Sales ⓘ	412	469	498	575	597	776	879	1,010	1,137	1,368	468
Sales YoY Gr.	-	13.7%	6.3%	15.3%	3.9%	30%	13.3%	14.9%	12.5%	20.4%	-
Adj EPS ⓘ	0.2	6	4.3	1.6	0.2	4.8	5.1	7.1	0.3	9.2	0
YoY Gr.	-	3227.8%	-28.6%	-62.4%	-89.4%	2717.7%	7.3%	37.6%	-95.2%	2617.7%	-
BVPS (₹) ⓘ	8.9	12.9	17.1	18	16.7	17.4	17.5	53.4	53.8	68.1	0
Adj Net Profit ⓘ	1.3	44.8	31.5	11.8	1.2	35.2	37.8	69	3.4	93.3	NAN
Cash Flow from Ops. ⓘ	30.7	27.3	30.5	-6.3	85.8	83.1	66.7	125	112	176	-
Debt/CF from Ops. ⓘ	4.1	12.1	11.5	-17.8	2.3	2.4	4.6	3.4	5.4	4.2	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	14.3%	18%	15.9%	20.4%
Adj EPS ⓘ	54.9%	122.4%	21.6%	2617.7%
BVPSⓘ	25.3%	32.4%	57.3%	26.7%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26	TTM
Return on Equity % ⓘ	2	55.4	28.6	9.2	1	28.1	29.4	21.2	0.6	15.4	0
Op. Profit Mgn % ⓘ	8.8	12.2	11.1	8.3	9.7	15.7	15.4	14.2	13.1	21.2	NAN
Net Profit Mgn % ⓘ	0.3	9.6	6.3	2.1	0.2	4.5	4.3	6.8	0.3	6.8	NAN
Debt to Equity ⓘ	1.9	3.5	2.8	0.8	1.6	1.5	2.4	0.8	1.2	1.1	-
Working Cap Days ⓘ	100	104	113	158	151	108	140	152	176	191	0
Cash Conv. Cycle ⓘ	-56	-65	-60	-53	-28	-24	-6	7	11	14	0

Valuation of Paras Healthcare - Consolidated

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Financials

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Sales	468.83	498.48	575.23	598.40	779.92	917.92	1,129.04	1,294.06	1,605.95
Operating Expenses ⓘ +	411.85	443.43	531.02	561.97	708.78	846.48	1,007.60	1,154.78	1,289.97
Manufacturing Costs	165.25	183.29	29.29	246.98	297.29	348.24	397.47	511.86	541.90
Material Costs	105.44	109.63	129.20	155.14	205.42	236.41	296.71	336.84	430.22
Employee Cost	70.39	71.92	88.09	86.44	100.04	133.69	167.26	173.81	181.57
Other Costs ⓘ	70.77	78.60	284.44	73.41	106.03	128.13	146.16	132.28	136.29
Operating Profit ⓘ	56.98	55.05	44.21	36.43	71.14	71.44	121.44	139.28	315.98
Operating Profit Margin (%)	12.2%	11.0%	7.7%	6.1%	9.1%	7.8%	10.8%	10.8%	19.7%
Other Income ⓘ +	32.57	26.88	29.78	16.81	13.25	18.13	35.37	20.14	22.83
Exceptional Items ⓘ	-8.57	-1.27	0	2	3.33	0	0	0	0
Interest ⓘ	12.10	10.30	25.79	31.68	33.26	51.15	69.46	93.88	119.21
Depreciation ⓘ	21.20	24.75	43.76	44.87	51.41	65.48	80.72	115.58	143.57
Profit Before Tax ⓘ	47.68	45.62	4.44	-21.31	3.05	-27.05	6.63	-50.04	76.03
Tax ⓘ	9.03	15.57	4.94	4.04	17.86	15.74	21.96	7.95	32.20
Profit After Tax	38.65	30.05	-0.50	-25.35	-14.81	-42.79	-15.33	-57.98	43.83
PAT Margin (%)	8.2%	6.0%	-0.1%	-4.2%	-1.9%	-4.7%	-1.4%	-4.5%	2.7%
Adjusted EPS (₹)	5.3	4.1	-0.1	-3.5	-2.0	-5.8	-1.6	-5.9	4.3
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Equity and Liabilities
Shareholders Fund +	94.87	124.86	113.39	88.12	73.11	30.11	338.51	280.49	394.60
Share Capital ⓘ	3.68	3.68	3.68	3.68	3.68	3.68	9.76	9.76	10.10
Reserves ⓘ	91.19	121.18	109.71	84.45	69.43	26.43	328.75	270.73	384.50
Debt +	312.86	333.17	111.29	180.61	191.46	362.20	506.78	663.99	777.64
Long Term Debt	303.55	317.24	74.23	121.85	139.39	255.42	358.40	436.44	454.21
Short Term Debt	9.30	15.94	37.06	58.76	52.07	106.78	148.38	227.55	323.43
Minority Interest	0	0	0	0	0	0	0	0	0
Trade Payables	66.61	66.97	84.98	100.86	119.23	123.73	137.48	190.54	208.10
Others Liabilities ⓘ	55.24	55.84	432.51	436.93	579.74	777.07	494.89	675.43	690.80
Total Liabilities ⓘ	529.57	580.84	742.16	806.52	963.53	1,293.10	1,477.66	1,810.45	2,071.14
Fixed Assets
Net Fixed Assets ⓘ +	125.94	180.22	427.09	413.62	485.51	779.95	987.72	1,173.41	1,210.64
Gross Block	144.02	223.05	513.62	531.73	636.05	982.27	1,256.79	1,544.57	1,699.12
Accumulated Depreciation	18.08	42.83	86.53	118.10	150.54	202.31	269.08	371.17	488.48
CWIP ⓘ	37.12	12.86	1.05	5.40	41.25	77.74	28.78	37.81	28.73
Investments ⓘ	201.18	22.28	0	0	0	0	0	0	0
Inventories	12.65	14.85	16.55	11	12.32	17.72	27.80	26.29	31.89
Trade Receivables	47.79	50.22	48.66	41.92	84.42	130.67	156.31	234.59	349.57
Cash Equivalents	5.13	195.98	4.57	254.14	198.10	161.71	160.29	205.52	302.73
Others Assets ⓘ	99.76	104.44	244.25	80.44	141.93	125.32	116.77	132.83	147.58
Total Assets ⓘ	529.57	580.84	742.16	806.52	963.53	1,293.10	1,477.66	1,810.45	2,071.14

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Cash Flow From Operating Activity ⓘ +	30.55	35.95	32.06	83.75	82.38	43.68	92.48	86.19	163.51
PBT ⓘ	47.68	45.62	4.44	-21.31	3.05	-27.05	6.63	-50.04	76.03
Adjustment ⓘ	14.49	22.29	53.57	89.81	121.69	163.17	129.48	206.96	250.42
Changes in Working Capital ⓘ	-19.59	-16.83	-7.82	24.04	-20.86	-60.09	-33.12	-60.92	-109.12
Tax Paid ⓘ	-12.03	-15.13	-16.15	-8.79	-21.50	-32.34	-10.51	-9.81	-53.82
Cash Flow From Investing Activity ⓘ +	-234	-47.83	-13.20	-74.34	-129.07	-126.21	-194.06	-147.25	-239.41
Capex	-40.15	-50.41	-77.07	-55.79	-138.36	-112.34	-194.71	-135.38	-168.83
Net Investments	-196.27	-2.42	0	-30.44	-1.14	-21.64	-7.64	-23.46	-85.89
Others ⓘ	2.42	5.01	63.87	11.89	10.42	7.77	8.29	11.59	15.31
Cash Flow From Financing Activity ⓘ +	205.25	19.15	-24.78	50.98	-10.60	97.47	93.98	82.82	85.89
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	69.13
Net Proceeds from Borrowing ⓘ	-14.19	21.41	0	51.58	23.57	85.40	110.96	102	30.57
Interest Paid ⓘ	-9.95	-8.89	-18.38	-11.08	-14.14	-41.94	-58.24	-97.93	-108.61
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0
Others ⓘ	229.39	6.63	-6.40	10.48	-20.04	54.01	41.26	78.75	94.81
Net Cash Flow ⓘ	1.81	7.27	-5.92	60.39	-57.30	14.94	-7.60	21.76	9.99

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Ratios
ROE (%)	40.74	27.35	-0.42	-25.16	-18.37	-82.92	-8.32	-18.73	12.99
ROCE (%)	14.05	12.39	8.62	4.07	12.69	6.77	11.61	4.63	17.3
Asset Turnover Ratio	0.89	0.9	0.87	0.77	0.88	0.81	0.82	0.79	0.83
PAT to CFO Conversion(x)	0.79	1.2	N/A	N/A	N/A	N/A	N/A	N/A	3.73
Working Capital Days
Receivable Days	37.20	35.90	31.40	27.60	29.60	42.80	46.40	55.10	66.40
Inventory Days	9.90	10.10	10	8.40	5.50	6	7.40	7.60	6.60
Payable Days	230.60	222.40	214.60	218.60	195.50	187.60	160.70	177.70	169.10

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Paras Healthcare Ltd FAQs

The current trading price of Paras Healthcare on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Paras Healthcare stood at ₹0.00 Cr

The latest P/E ratio of Paras Healthcare as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Paras Healthcare as of 31-Dec-1969 is 0.00.

The 52-week high of Paras Healthcare is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Paras Healthcare is ₹468 ( Cr.) .

Data is not available for this company.

No data found

About Paras Healthcare Ltd

Paras Healthcare was incorporated as ‘Arbian Frozen Foods Private Limited’, a private limited company under the provisions of the Companies Act, 1956, pursuant to a certificate of incorporation dated December 21, 1987, issued by the Registrar of Companies, Delhi & Haryana at New Delhi.

The company is a clinical specialty-led hospital platform providing tertiary and quaternary healthcare services. It operates under the “Paras Health” brand. The company operates its hospitals through a mix of owned, leased, revenue-sharing and public-private partnership models, and have adopted a calibrated approach to capital deployment, evaluating capital-efficient structures selectively based on market characteristics, capital efficiency considerations and long-term operating control. The company’s leased facilities are structured through fixed rent, revenue sharing or hybrid arrangements comprising a partial fixed rent and a partial revenue share. Its growth decisions are guided by defined return thresholds and the strength of its balance sheet.

The company’s hospitals have modern operating theatres (OTs), procedure rooms and intensive care units (ICUs) built to rigorous design, safety and technology standards. These facilities are underpinned by advanced equipment from globally reputed manufacturers, including biplane cath labs, MRI machines, radiotherapy systems, linear accelerators (LINACs), surgical robots, PET-CT scanners, neuro and ortho navigation systems, O-arm surgical imaging systems, endoscopic ultrasound (EUS) and endobronchial ultrasound (EBUS) systems, and are built to deliver complex care at scale. The company’s critical care infrastructure spans organ and condition-specific ICUs, enabling focused and protocol-driven care. It operates dedicated cardiac, neuro, liver transplant, kidney transplant, bone marrow transplant, extracorporeal membrane oxygenation (ECMO)-enabled, neonatal, paediatric, medical and surgical ICUs. For immuno-compromised and post-transplant patients, it maintains dedicated ICU rooms equipped with laminar airflow systems and strict infection-control protocols to minimise the risk of cross-infection.

Business area of the company

The company is a leading clinical specialty-led hospital platform providing tertiary and quaternary healthcare services under the ‘Paras Health’ brand. The company operates its hospitals through a mix of owned, leased, revenue-sharing and public-private partnership models, and have adopted a calibrated approach to capital deployment, evaluating capital-efficient structures selectively based on market characteristics, capital efficiency considerations and long-term operating control.

Awards, accreditations or recognitions

2009: Paras Hospital, Gurugram was the first hospital in Haryana to receive the accreditation by the National Accreditation Board for Hospital & Healthcare Providers.
2009: Accreditation for Paras Hospitals – Laboratory Sciences, Gurugram by the National.
2009: Accreditation Board for Testing and Calibration Laboratories.
2015: Paras HMRI Hospital, Patna received the certificate of recognition for being “First Multi Specialty Hospital in Bihar Jharkhand Region” at the 5th Elets Healthcare Leaders Forum Bengal, 2015.
2016: Paras HMRI Hospital, Patna was awarded ‘Maximum Outreach Hospital of the Year’ by Assocham, India.
2016: Paras HMRI Hospital, Patna was the first hospital in Bihar to receive the accreditation by the National Accreditation Board for Hospital & Healthcare Providers.
2018: Paras HMRI Hospital, Patna was awarded in the “Super Speciality Hospital” category at the Assocham National Leadership Excellence Awards 2018 by Assocham, India.
2019: Paras HMRI Hospital, Patna was awarded “Best Multispeciality Hospital” by Assocham.
2021: Awarded “Best Hospital for COVID Care” by 11th MT Healthcare Awards.
2021: Paras Hospitals, Udaipur received the “Responsible Recycler Certificate” from Greenscape Eco Management Private Limited for handing over e-waste for the purpose of sound e-waste recycling.
2021: Paras Hospital, Gurugram was awarded the silver award in the “Women Health Brand” category at the 7th IHW Awards 2021 by IHW Council.
2021: Accreditation for Paras Hospital, Panchkula by the National Accreditation Board for Hospital & Healthcare Providers.
2021: Accreditation for Paras Hospital, Udaipur by the National Accreditation Board for Hospital & Healthcare Providers.
2021: Paras Global Hospital, Darbhanga received certification for complying with NABH entry level hospital requirement by the National Accreditation Board for Hospital & Healthcare Providers.
2022: Paras HMRI Hospital, Patna was awarded “Best Clean Energy Initiative in Healthcare (Best Energy Saving Hospital)” at the “The Business Tycoon Award”.
2022: Paras HMRI Hospital, Patna was awarded “Most Advanced Hospital” at the “The Business Tycoon Award”.
2022: Paras HMRI Hospital, Patna received the “Service Excellence Award” by Prabhat Khabar Sanjeevani Awards-2022.
2023: Paras Hospital, Panchkula, received the Award for “Leading hospital in Advanced Technologies” by the MY FM at MY FM Excellence Award.
2024: Received the GOLD award for Hospital with Best Adaptation to Digital Health Technology at 3rd IHW Digital Health Awards, 2024 by the IHW Council.
2024: Recognised as ‘one of the Best Healthcare Brands-2024’ by ET Edge.
2024: Paras Health, Panchkula, was awarded the ‘Excellence in Cardiac & Cancer Care’ at the Red Achievers Award, 2024 by Red FM.
2024: Accreditation for Paras HEC Hospital, Ranchi by the National Accreditation Board for Hospital & Healthcare Providers.
2024: Paras Hospital, Gurugram received the Gold award for ‘Smart & Future-Ready Neurology Hospital' by the IHW Council at the IHW Smart Hospitals & Diagnostics Awards.
2024: Paras HMRI Hospital, Patna received the Silver award for ‘Smart & Future-Ready ER & Critical Care Hospital’ by the IHW Council at the IHW Smart Hospitals & Diagnostics Awards.
2024: Paras Hospital, Panchkula received the Silver award for ‘Smart & Future-Ready Cancer Hospital’ by the IHW Council at the IHW Smart Hospitals & Diagnostics Awards.
2024: Paras Global Hospital, Darbhanga received the Gold award for ‘Smart and Future-ready Nephrology care Hospital’ by the IHW Council at the IHW Smart Hospitals & Diagnostics Awards.
2024: Paras HEC Hospital, Ranchi received the Silver award for ‘Smart & Future-Ready OBS & Gynae Hospital’ by the IHW Council at the IHW Smart Hospitals & Diagnostics Awards.
2024: Paras Hospital, Srinagar received the Bronze award for ‘Smart & Future-Ready Heart Care Hospital’ by the IHW Council at the IHW Smart Hospitals & Diagnostics Awards.
2024: Paras Hospital, Udaipur received the Bronze award for ‘Robotics for Patient Care’ by the IHW Council at the IHW Smart Hospitals & Diagnostics Awards.
2024: The company received the Gold award for ‘Smart & Future Ready Multi Speciality Hospital Chain’ by the IHW Council at the IHW Smart Hospitals & Diagnostics Awards.
2024: The company received the Gold award for ‘Smart & Future Ready Hospital Management’ by the IHW Council at the IHW Smart Hospitals & Diagnostics Awards.
2024: Paras Yash Kothari Hospital, Kanpur received the Gold award for ‘Patient Centric Smart Hospital Design’ by the IHW Council at the IHW Smart Hospitals & Diagnostics Awards.
2024: Paras Hospital, Gurugram ranked No. 6 in Bariatrics in Faridabad and Gurgaon City in the All India Lifestyle Hospital & Clinic Ranking Survey 2024 by Times Health Survey.
2024: Paras Hospital, Gurugram ranked No. 4 nationally in Orthopedics in the All India Lifestyle Hospital & Clinic Ranking Survey 2024 by Times Health Survey.
2024: Paras Hospital, Gurugram ranked No. 3 in Orthopedics in the North Region in the All India Lifestyle Hospital & Clinic Ranking Survey 2024 by Times Health Survey.
2024: Paras Hospital, Gurugram ranked No. 1 in Orthopedics in Faridabad and Gurgaon City in the All India Lifestyle Hospital & Clinic Ranking Survey 2024 by Times Health Survey.
2024: Paras Hospital, Gurugram ranked No. 8 in Ophthalmology in Faridabad and Gurgaon City in the All India Lifestyle Hospital & Clinic Ranking Survey 2024 by Times Health Survey.
2024: Paras Hospital, Gurugram ranked No. 7 in Diabetology in Faridabad and Gurgaon City in the All India Lifestyle Hospital & Clinic Ranking Survey 2024 by Times Health Survey.
2024: Paras Hospital, Panchkula ranked No. 6 nationally in Plastic Surgery in the All India Lifestyle Hospital & Clinic Ranking Survey 2024 by Times Health Survey.
2024: Paras Hospital, Panchkula ranked No. 4 in Plastic Surgery in the North Region in the All India Lifestyle Hospital & Clinic Ranking Survey 2024 by Times Health Survey.
2024: Paras Hospital, Gurugram ranked No. 5 nationally in IVF and Fertility in the All India Lifestyle Hospital & Clinic Ranking Survey 2024 by Times Health Survey.
2024: Paras Hospital, Gurugram ranked No. 2 in IVF and Fertility in the North Region in the All India Lifestyle Hospital & Clinic Ranking Survey 2024 by Times Health Survey.
2025: Paras Hospital, Kanpur was awarded “Best Multi Speciality Hospital in Kanpur” award at the Big Impact Awards, 2025.
2025: Paras Health Group ranked No. 4 - National in the “Multi-Speciality Group of Hospital” category by Times Now Health Ranking Survey at the India Health Summit & Awards, 2025.
2025: Paras Health Group was awarded as “Lead 50 Cybersecurity (North Based HO)” category by Alden Global's Cyber Security & Tech.
2025: Paras Hospital, Panchkula was awarded as “Pioneer in Leading Hospital in Neurosciences” by Times of India.
2025: Paras Hospital, Panchkula was awarded “Excellence in Radiation Oncology” at Tribune Lifestyle Awards 2025 - Season 2 by the Tribune.
2025: Paras Hospital, Panchkula was awarded “Pioneer in Arthroscopy & Sports Injury” by Times of India at Healthcare Pioneers, Haryana.
2025: Paras Hospital, Panchkula was awarded “Healthcare Pioneers” for the “Region’s Leading Stroke Ready Hospital” by Times of India.
2025: Paras Hospital, Panchkula was awarded “Healthcare Pioneers” in the category “Excellence in Renal Transplant” by Times of India.
2025: Paras Hospital, Panchkula was awarded “A Leading Multi Speciality Hospital” for its outstanding contribution and excellence by Dainik Bhaskar at the “Chandigarh Eminence Awards” 2025.
2025: Paras Hospital, Panchkula was awarded “Pioneer in Stem Cell Transplantation” by ZEE Punjab Haryana Himachal at “Health Conclave” 2024-2025.
2025: Paras Hospital, Panchkula was awarded “Best Neuroscience Specialty Hospital” by ZEE Punjab Haryana Himachal at “Health Conclave” 2024-2025.
2025: Paras Hospital, Panchkula was awarded “Excellence in Joint Replacement Surgery” at the Tribune Achievers Awards, 2025.
2026: Paras Hospital, Kanpur was awarded “Excellence in Oncology Hospital of the Year” by IHW Council at the 7th edition of Cancer Summit & Awards.
2026: Paras Healthcare Limited has been recognized as “Great Place to Work” by Great Place to Work, India.
2026: Paras Hospital, Panchkula was awarded “Leading Hospital in Neurosciences” by the Times of India.

History and milestones

2006: Established and commenced operations of its first hospital at Gurugram, Haryana.
2013: Established and commenced operations of Paras HMRI Hospital, Patna, Bihar.
2016: Established and commenced operations of Paras Global Hospital, Darbhanga.
2017: Raised investment of Rs 2.60 billion from the investor, Commelina Ltd.
2017: Performed its first bone marrow transplant procedure at Paras HMRI Hospital, Patna.
2018: Established and commenced operations of Paras Hospitals, Panchkula, Haryana.
2018: Performed its first kidney transplant procedure at Paras HMRI Hospital, Patna.
2019: Commenced operations of two new hospitals: Paras HEC Hospital, Ranchi, Jharkhand and Paras Hospital, Udaipur, Rajasthan.
2023: Expanded Paras HEC Hospital, Ranchi to 300 beds capacity and additional tertiary care.
2023: Established and commenced operations of its Paras Hospitals, Srinagar, Jammu & Kashmir.
2023: Performed its first bone marrow transplant procedure at Paras Hospital, Gurugram.
2024: Established and commenced operations of its Paras Yash Kothari Hospital, Kanpur, Uttar Pradesh.
2024: Performed its first robotic surgery at Paras Hospital, Gurugram.
2024: Performed its first robotic surgery at Paras Hospital, Udaipur.
2024: Performed its first liver transplant procedure at Paras Hospital, Gurugram.
2024: Performed its first kidney transplant procedure at Paras Hospitals, Panchkula, Haryana.
2025: Raised investment of Rs 587.00 million from the investor 360 ONE Special Opportunities Fund - Series 12.
2025: Raised investment of Rs 213.00 million from the investor Axis New Opportunities AIF - Series II.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Paras Healthcare Ltd (PARASHLTH)

Paras Healthcare Ltd (PARASHLTH)

10 Year X-Ray :